To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions
NCT ID: NCT00913952
Last Updated: 2017-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
18 participants
INTERVENTIONAL
1994-04-30
1994-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets
NCT00913419
Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
NCT00759993
Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body
NCT00800280
Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males
NCT00814931
Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals
NCT05971524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions.
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions
2
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions.
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
3
Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions.
Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Treatment for drug or alcohol dependence.
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sandoz
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandoz Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Lalonde, Pharm.D.
Role: PRINCIPAL_INVESTIGATOR
Phoenix International Life Science Inc.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
940155
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.